niceritrol has been researched along with Blood Pressure, High in 2 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Oida, K | 1 |
Nakai, T | 1 |
Tamai, T | 1 |
Kutsumi, Y | 1 |
Kobayashi, T | 1 |
Hayashi, T | 1 |
Yamada, S | 1 |
Takeda, R | 1 |
Hamazaki, T | 1 |
Hasunuma, K | 1 |
Kobayashi, S | 1 |
Shishido, H | 1 |
Yano, S | 1 |
2 other studies available for niceritrol and Blood Pressure, High
Article | Year |
---|---|
Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Topics: Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hypertension; Hypolipoprotein | 1982 |
The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritrol (Perycit) and a low dose of acetylsalicylic acid.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Viscosity; Diabetes Mellitus; Female; Fibrinogen; Huma | 1985 |